NCT04857008 - BNT001 Digital Therapeutic Feasibility Pilot Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

August 5, 2022

Study Completion Date

August 5, 2022

Conditions

Cancer

Interventions

DEVICE

BNT001

BNT001 is a commercially-available, prescription-only, software / medical device in the form of a digital application (digital app) for use on the participant's mobile device which delivers 10-sessions on cognitive behavioral therapy for cancer patients.

Trial Locations (1)

27705

Durham Veterans Administration, Durham